Article info

Two-year outcomes of intravitreal ziv-aflibercept


  1. Correspondence to Dr Jay Chhablani, Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad, Andhra Pradesh 500034, India; jay.chhablani{at}
View Full Text


Mansour AM, Ashraf M, Charbaji A On behalf of Ziv-aflibercept study group investigators, et al
Two-year outcomes of intravitreal ziv-aflibercept

Publication history

  • Received 9 November 2017
  • Revised 26 December 2017
  • Accepted 28 December 2017
  • Published online 9 January 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.